NABAKKA JULIET,MOLTENI VALENTINA,PETRASSI HANK MICHAEL JAMES
申请号：
AP201407493
公开号：
AP201407493A0
申请日:
2012.08.29
申请国别(地区):
AP
年份:
2014
代理人:
摘要：
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRalpha, PDGFRbeta) kinases.
